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Abstract Tissue factor (TF)–bearing microvesicles (MVs) and exosomes may play a role in
hemostasis and thrombosis. MVs may be quantified by flow cytometry (FC)–based
detection of phosphatidylserine (PS)-positive submicron particles carrying specific
antigens, although interference from lipoproteins complicates this approach. In this
study, we evaluated the effect of food intake on blood levels of TF-bearing particles
measured by FC and small extracellular vesicles (EVs) measured by a protein micro-
array–based test termed EV Array. Platelet-free plasma (PFP) was obtained from 20
healthy persons in the fasting state and 75 minutes after consumption of a meal.
Postprandial changes in the concentration of PS-positive particles, including subgroups
binding labeled antibodies against TF, CD41, CD146, and CD62E, respectively (FC),
small EVs (EV Array), and TF antigen and procoagulant phospholipids (PPLs) were
measured. Furthermore, we tested the effect on FC results of in vitro addition of
lipoproteins to fasting PFP. We found significantly increased plasma concentrations of
PS-positive particles and all examined subgroups postprandially, while no changes in
small EVs, PPL, or TF antigen levels were found. Levels of all types of particles measured
by FC were also elevated by lipoprotein spiking. In conclusion, meal consumption as
well as in vitro addition of lipoproteins to fasting plasma induces increased levels of PS-
positive particles as measured by FC, including TF-positive subtypes and subtypes
exposing other antigens. While the observed postprandial increasemay to some extent
reflect elevated MV levels, our results indicate a substantial interference from
lipoproteins.
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Introduction
Tissue factor (TF) has been established as a pivotal element in
activation of the clotting cascade.1 It is well described that TF
expressed subendothelially in blood vessels comes into con-
tact with blood upon tissue injury and, in combination with
activated FVII, initiates the coagulation process.2 However,
TF is also produced in monocytes and may furthermore be
expressed in platelets and activated endothelial cells.1 In
plasma, TF circulates both in its full-length form incorpo-
rated in the membranes of circulating cell–derived extra-
cellular vesicles (EVs) and in an alternatively spliced soluble
form.3–5 The role of blood-borne TF in the coagulation
process is not clear,2,5 but TF-bearing EVs (TFþ EVs) have
been suggested to play a role in hemostasis and thrombus
formation,6,7 and TF activity and TFþ EVs quantitated by
flow cytometry (FC) have been shown to be increased in
various thrombogenic conditions.1
Although consensus on the nomenclature of different
types of EVs has not been achieved,8 smaller sized EVs,
typicallywith a diameter of less than 150 nm,maybe termed
exosomes, whereas larger EVs are often referred to as
microvesicles (MVs).9 While these two types of EVs are
formed and released from cells by differentmechanisms,10,11
indications exist that both types possess the ability to carry
TF in their phospholipid bilayer membrane.1,5
A significant postprandial increase in plasma concentra-
tion of particles within the size range of exosomes and MVs
has been demonstrated using nanoparticle tracking analy-
sis12 and tunable resistive pulse sensing (TRPS).12,13 How-
ever, these methods lack the ability to distinguish between
EVs and other submicron particles, including phospholipid
monolayer–bounded lipoproteins such as chylomicrons,
low-density lipoproteins (LDLs), and very low-density lipo-
proteins (VLDLs), which are present in plasma and display an
altered relative distribution postprandially.13,14 FC enables
some characterization of the particles by fluorescence-based
detection of phosphatidylserine (PS) combined with cell-
type specific antigens and it has previously been reported in
FC-based studies that blood concentrations of MVs are
increased in the postprandial state.15–17 However, recent
investigations have indicated thatMVmeasurement by FC on
plasma may suffer from considerable interference from
lipoproteins, which are not eliminated by state-of-the-
art MV isolation methods.13 Although PS is a well-estab-
lished marker of MVs10,18,19 and has been used for MV
labeling in FC-based investigations,13,16 the sensitivity18 as
well as the specificity20 of PS-positive (PSþ) particles as
indicators of MVs can be questioned.
EV Array is a protein microarray–based technique
designed for measurement of small EVs.21 Biotinylated anti-
bodies against CD9, CD63, and CD81, often regarded as
exosome markers, but actually also present in MVs,22 can
be used in EV Array for sensitive detection of small EVs.21
The aim of this studywas to investigate the impact of food
ingestion on plasma levels of PSþ particles (using FC) and
small EVs (using EV Array) in general and their TF-bearing
subtypes inparticular aswell as the effect of prandial state on
levels of circulating TF antigen (Ag), TF activity, and procoa-
gulant phospholipids (PPLs). Considering the recent ques-
tioning of the reliability of FC-basedMVmeasurements,13we
evaluated the impact of prandial state and, parallelly, the
impact of in vitro addition of lipoproteins to fasting plasma
on levels of particles positive and negative for PS and other
markers indicating cell origin, discussing the potential influ-
ence of lipoproteins on postprandial changes of these ana-
lytes and the resulting limitations of FC inMVmeasurements
on plasma.
Materials and Methods
Study Population and Sample Handling
In this study,whichwas approved by the local research ethics
committee, we analyzed platelet-free plasma (PFP) samples
from 20 volunteers (13 females and 7 males) with a median
age of 44 (interquartile range [IQR], 33–58) years who were
considered healthy based on a health status questionnaire.
Additional blood tests were performed to screen for ongoing
disease and tomeasure total cholesterol and triglyceride (TG)
concentrations in the fasting and postprandial samples. From
each person, a fasting venous blood samplewas collected in a
9-mLVacuette 3.2% sodium citrate plastic tube (Greiner Bio-
One, Kremsmünster, Austria) in the morning before con-
sumption of a nonstandardized breakfast with a choice of
bread, butter, cheese, jam,marmalade, cake, coffee, tea, milk,
and sugar. Seventy-five minutes following commencement
of breakfast, a postprandial sample was collected. The first
3.5mL of blood from each sampling were discarded. Samples
were centrifuged twice at 2,500 g for 15 minutes at room
temperature, as recommended by Lacroix et al,23 to obtain
PFP, which was stored at 80°C until analysis.
Flow Cytometry
Plasma levelsofMVswereevaluatedbyamodifiedFCapproach
basedonapreviouslydescribedmethod,24usingaBDFACSAria
III High Speed Cell Sorter (BD Biosciences, San Jose, California,
United States). For each analysis, 50 μL of freshly thawed PFP
were transferred to a TruCount tube (BD Biosciences) contain-
ing a lyophilized pellet, releasing a known number of fluor-
escent beads as an internal standard and enabling particle
concentration determination according to the insert instruc-
tion of the manufacturer. Subsequently, 7 µL of fluorescein
isothiocyanate (FITC)–conjugated lactadherin (Haematologic
Technologies Inc., Essex Junction, Vermont, United States)
were added to each sample, utilizing the binding affinity of
lactadherin for PS,25 to label particles exposing PS. All particles
within the defined size gate (see below) were collectively
designated as particles. Particles positively stained with FITC-
conjugated lactadherin (which binds to PS)were designated as
PSþ particles. To identify PSþ particles originating fromplate-
lets,26 particles were further labeled with 3 µL of allophyco-
cyanin-conjugated antihuman CD41 IgG1, κ (BioLegend, San
Diego, California, United States). We identified endothelium-
derived particles27 by labeling with 20 µL of phycoerythrin
(PE)-conjugated antihuman CD146 IgG1, κ (BD Biosciences),
and furthermore activatedendothelium-derivedparticles27by
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labelingwith20 µLofPE-conjugatedantihumanCD62E IgG1,κ
(BDBiosciences). TF-bearing (TFþ) particleswere identifiedby
labeling with 20 µL of PE-conjugated antihuman TF IgG1, κ
(BioLegend). TFþ particles that were not positively stained
with FITC-conjugated lactadherin were designated TFþ PS
particles. Isotype controls matching each antibody were used
as negative controls. After 30 minutes of incubation at 4°C in
the dark, 200 µL ofDulbecco’s phosphate-buffered saline (PBS)
buffer (Lonza, Basel, Switzerland) that had been filtered
through a sterile 0.2-µm Q-Max syringe filter (Frisenette,
Knebel, Denmark) were added to each labeled sample. A size
gate was established by preliminary standardization experi-
ments using a blend of size-calibrated fluorescent polystyrene
beads with sizes ranging from 0.2 to 0.9 μm. The upper and
outer limits of the gate were established just above the size
distribution of the 0.9-µmbeads and the lower limit was set to
include the 0.2-µm beads to obtain a size gate of about 0.2–
1.0 µm in a forward (FSC) and side scatter (SSC) setting. A
discriminatorwas set to 200 at the SSC-Hparameter (insteadof
FSC-H) to avoid exclusion of smaller sized particles. Event
numbers were counted at a maximal flow rate of 20,000
events/second and stopped after 60 seconds or when
the MV gate reached at least 500,000 events. Flow rates of
postprandial samples with increased particle numbers were
adjusted to comply with the maximal flow rate limit.
To study the effect of in vitro addition of lipoproteins to
plasma, four fasting PFP samples were spiked with an LDL
isolate and a VLDL isolate, respectively, prior to the same
labeling and incubation steps and FC analysis as described
above. However, it was performed at a later time point on
different plasmas and different batches of antibodies. One
part of human LDL 5 mg/mL (Kalen Biomedical, Montgomery
Village, Maryland, United States) was added to 10 parts of
PFP and, parallelly, 1 part of human VLDL 1 mg/mL (Kalen
Biomedical) was added to another 10 parts of PFP, resulting
in increases in TG concentration of 0.1 and 0.2 mmol/L, and
increases in cholesterol concentration of 2.2 and 0.2 mmol/L,
respectively. As controls, we tested the effect of addition of
the LDL and VLDL isolates and performing the incubation
steps on samples not containing PFP, which was, in these
control samples, replaced by an equal amount of PBS.
EV Array
For small EV analysis, EV Array, allowing for quantification
and phenotyping of this EV subtype, was applied. Micro-
array slides were printed as described by Jørgensen et al,28
and the following antibodies or proteins were printed: anti-
CD63, anti-CD41 (Biolegend), anti-CD9, anti-CD81 (LifeSpan
BioSciences, Inc., Seattle, Washington, United States), anti-
human TF (R&D Systems Inc., Minneapolis, Minnesota,
United States), anti-CD146 (P1H12, Abcam, Massachusetts,
United States), anti-CD62E (Thermo Scientific, Waltham,
Massachusetts, United States), and lactadherin (Haemato-
logic Technologies). All antibodies and proteins were
printed in triplicates at 200 µg/mL diluted in PBS containing
5% glycerol.
Catching and visualization of the EVs were performed as
described previously by Jørgensen et al29 with the following
modifications: After blocking, 10 µL of freshly thawed PFP
diluted in wash buffer (0.05% Tween 20 [Sigma-Aldrich, St.
Louis, Missouri, United States] in PBS) were incubated at
room temperature for 2 hours followed by an overnight
incubation at 4°C. Following a wash, the slides were incu-
bated for 2 hours with detection antibodies. The detection
was performed with an “exosome cocktail,” which is a
combination of fluorescently labeled versions of the exo-
some-related markers anti-CD9, anti-CD63, and anti-CD81
(Ancell Corporation, Stillwater, Minnesota, United States)
diluted 1:1,500 in wash buffer. After a wash, a subsequent
30-minute incubation step with cyanine 5 (Cy5)–labeled
streptavidin (1:1,500; Life Technologies, Carlsbad, California,
United States) in wash buffer was performed for detection.
Prior to scanning at 635 nm, the slides were washed once in
wash buffer and once in MilliQ water and dried using a
Microarray High-Speed Centrifuge (ArrayIt, Sunnyvale, Cali-
fornia, United States). Scanning and spot detection was
performed as previously described.29
Additional Analyses
PPL-dependent clotting time (PPL-CT) was measured with
STA Procoag PPL (Diagnostica Stago, Asnières, France) on an
STA Compact Coagulation Analyzer (Diagnostica Stago).
TF Ag was measured by Imubind antihuman Tissue Factor
ELISA (Sekisui Diagnostics, Lexington, Massachusetts,
United States) using a SpectraMax M2 Microplate Reader
(Molecular Devices, Sunnyvale, California, United States)
measuring the absorbance at a wavelength of 450 nm. In
the following, we refer to this method as TF AgELISA.
A supplemental method for TF Ag measurement, repre-
sented by a modified version of EV Array with polyclonal
anti-TF antibodies (R&D Systems Inc.) as capturing agents
and biotin labeled polyclonal anti-TF antibodies (R&D Sys-
tems Inc.) as detecting agents, was applied and designated TF
AgEV Array.
TF activity was evaluated with Tissue Factor Human
Chromogenic Activity Assay Kit (Abcam, Cambridge, UK),
and the absorbance at awavelength of 405 nmwasmeasured
with SpectraMaxM2Microplate Reader (Molecular Devices).
Lipid levels were measured as routine analyses at the
Department of Clinical Biochemistry, Aalborg University
Hospital, using a Cobas 8000 Modular Analyzer (Roche
Applied Science, Penzberg, Germany).
Statistics
Statistical analyseswere performed andgraphs createdusing
GraphPad Prism, version 6.01 (GraphPad Software, Inc., La
Jolla, California, United States). Data, for which a normal
distribution was not rejected when applying the Anderson–
Darling test, were presented with mean value and standard
deviation (SD), while p-value for pairwise comparison was
calculated using paired t-test and degree of correlation
indicated by Pearson’s r. Data, for which a normal distribu-
tion was rejected, were presented with median value and
IQR, while p-value for pairwise comparison was evaluated
using Wilcoxon’s matched pairs signed-rank test and degree
of correlation indicated by Spearman’s rs.
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Two-sided p-values were given, and values below 0.05
considered significant.
Pooled coefficient of variation (CV) indicating the degree of
consistency of results was calculated as the square root of the
mean of the squared CVs for measurements on each subject.
Results
Flow Cytometry
FC results on the fasting and postprandial samples are shown
in ►Fig. 1 (concentrations of total and PSþ particles for each
subject) and ►Fig. 2 (levels of antibody labeled subtypes).
The concentration of total particles increased substantially in
all subjects after food intake, the median rise being 14-fold
(IQR, 5–30-fold). A less extensive, yet clearly statistically
significant, postprandial increase in the concentration of
PSþ particles and all studied subtypes of these, including
TFþ PSþ particles, was observed. The relative increases from
fasting to postprandial state are shown in►Table 1. Total TFþ
particles (i.e., TFþ PSþ and TFþ PS particles) were also
detected and TFþ PS particles constituted a considerable
part of all TFþ particles and increased even more postpran-
dially. Representative scatter plots of TFþ PSþ events in a
fasting and a postprandial sample are shown in ►Fig. 3A, B.
Also shown in ►Table 1 are the relative increases after
addition of lipoproteins in vitro. The absolute numbers are
shown in ►Figs. 1 and 2. This investigation was performed
later than the previous investigation on the fasting/post-
prandial samples, and generally the numbers of particles
were lower, but the data indicate that spiking PFP with either
LDL or VLDL results in variably increased levels of measur-
able total particles, PSþ particles, and subgroups staining
positive for TF, CD41, CD146, and CD62E, respectively. Since
the measurements on samples with added VLDL or LDL
showed an increased level of the particles measured in
each subgroup after addition, it is highly significant for
most of the subgroups: for each subgroup, p < 0.005,
n ¼ 8 (►Table 1). Representative scatter plots of TFþ PSþ
events in a fasting sample before and after addition of VLDL
are shown in ►Fig. 3C, D. In control samples, where PBS was
spiked with LDL and VLDL, none of the antibody-labeled
subtypes of PSþ particles appeared.
EV Array
Fasting and postprandial fluorescence intensities measured
with EVArray are shown in►Fig. 4. No significant differences
between the fasting and postprandial samples were found.
CD62Eþ EVs were undetectable in the majority of the study
participants, while the other investigated subgroups, includ-
ing TFþ EVs and PSþ EVs (lactadherin capture), were
detected in most subjects. We observed a substantial varia-
tion and markedly lower fluorescence intensities, including
several below the detection limit, using anti-CD63 antibo-
dies as compared with anti-CD9 and anti-CD81 antibodies.
Results on the two last-mentioned exhibited consistency
between fasting and postprandial results, showing a very
low difference between the two measurements.
PPL, TF Antigen, and TF Activity Analysis
Results on biological variation in PPL-CT and TF Ag levels as
measured by TFAgELISA and TFAgEVArray are given in►Table 2.
No significant difference between fasting and postprandial
Fig. 1 Fasting and postprandial concentration of (A) total particles and (C) phosphatidylserine-positive (PSþ) particles measured by flow
cytometry and, for comparison, fasting plasma before and after addition of VLDL or LDL (B and D). Lines combine fasting levels (open circles) with
postprandial levels (closed circles) for each study participant, and for the additional study the levels before (open circles) and after addition of
VLDL (blue closed circles) and LDL (red closed circles). Small bars to the left of the fasting and to the right of the postprandial results (or after
addition of VLDL [blue] or LDL [red]) indicate the median of all results.
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Fig. 2 Fasting and postprandial concentration of (A) total tissue factor-positive (TFþ) particles, (C) TFþ phosphatidylserine-positive(PSþ)
particles, (E) TFþ phosphatidylserine-negative (PS) particles, (G) CD41þ PSþ particles, (I) CD146þ PSþ particles, and (K) CD62Eþ PSþ
particles measured by flow cytometry. The results for the same particle subtypes before and after addition of VLDL or LDL to fasting plasma are
shown in B, D, F, H, J (only three results for VLDL due to technical problems), and L, respectively. Lines combine fasting levels (open circles) with
postprandial levels (closed circles) for each study participant, and for the additional study the levels before (open circles) and after addition of
VLDL (blue closed circles) and LDL (red closed circles). Small bars to the left of the fasting and to the right of the postprandial results (or after
addition of VLDL [blue] or LDL [red]) indicate the median of all results.
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Table 1 Changes in particle concentrations after food intake or in vitro lipoprotein addition
Study Median (IQR) postprandial
rise, (%) (n ¼ 20)
Median (range) rise after
VLDL addition, (%) (n ¼ 4)
Median (range) rise after
LDL addition, (%) (n ¼ 4)
Total particles 1,385 (542–2,961) 365 (31–603) 271 (23–434)
Total PSþ particles 63 (26–245) 379 (107–527) 341 (56–683)
TFþ PSþ particles 98 (48–213) 132 (74–373) 172 (26–336)
TFþ PS particles 449 (171–1460) 272 (34–382) 189 (12–263)
Total TFþ particles 143 (69–311) 266 (41–337) 201 (15–251)
CD41þ PSþ particles 103 (8–183) 18 (11–31) 8 (1–15)
CD146þ PSþ particles 49 (11–121) 25 (6–157)a 36 (1–150)
CD62Eþ PSþ particles 307 (134–560) 25 (17–77) 61 (1 to 101)
Abbreviations: IQR, interquartile range; LDL, low-density lipoprotein; PSþ , phosphatidylserine-positive; PS , phosphatidylserine-negative; TFþ ,
tissue factor–positive; VLDL, very low-density lipoprotein.
Note: Effect of meal consumption or in vitro addition of VLDL or LDL on relative concentrations of total particles, total PSþ particles, TFþ PSþ
particles, TFþ PS particles, total TFþ particles, CD41þ PSþ particles, CD146þ PSþ particles, and CD62Eþ PSþ particles in platelet-free plasma
(PFP) measured by flow cytometry.
p < 0.01; p < 0.001; p < 0.0001; p < 0.005 for the combined VLDL and LDL additions.
aOnly three determinations.
Fig. 3 Representative flow cytometry scatter plots of (A) fasting and (B) postprandial PFP samples from one healthy donor and a sample before
(C) and after (D) addition of VLDL. The number of TruCount beads and the number of TF PSþ and TFþ PSþ particles are given in quadrant 1 (Q1)
and 2 (Q2), respectively. Increased particle numbers lead to a higher coincident rate. Flow rates were, therefore, adjusted in postprandial
samples with many events to maintain event rates below the maximal flow rate limit (<20,000 events/second) and thereby reduce coincident
detection. Note: A lower flow rate reduces both the numbers of TruCount beads (the framed dots in quadrant 2) and PSþ events acquired in the
postprandial scatter plot (B).
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samples was observed by pairwise comparison. Fasting and
postprandial values for each subject are given in►Fig. 5A–C.
TF activity levels asmeasured by the chromogenic assaywere
below the limit of detection for all participants in the fasting
as well as the postprandial state. A positive correlation was
found between TF AgELISA and TF AgEV Array in both post-
prandial (►Fig. 6A) and fasting samples. Neither levels of
TFþ PSþ particles (FC) nor TFþ EVs (EV Array) were signifi-
cantly correlated with TF Ag levels in neither fasting nor
postprandial samples. However, total TFþ particles (i.e.,
TFþ PS and TFþ PSþ particles measured with FC) corre-
lated moderately (rs ¼ 0.46; p ¼ 0.04) with TF AgEV Array on
the fasting samples and nonsignificantly with TF AgELISA
(rs ¼ 0.40; p ¼ 0.09). PPL-CTs did not correlate with PSþ
particle concentrations.
Lipid Level Determination
Fasting and postprandial total cholesterol and TG concentra-
tions for each subject are given in ►Fig. 5D, E. TG concentra-
tions were significantly higher in the postprandial as
compared with the fasting samples (p < 0.001) with a
mean increase of 0.2 mmol/L or 22%. No significant change
in total cholesterol concentration was observed. A positive
correlation was found between TG concentrations and total
particle levels as measured by FC in postprandial (►Fig. 6B)
but not fasting samples.
Fig. 4 Fasting and postprandial content of small extracellular vesicles (EVs) in general ((A) anti-CD9, (B) anti-CD63, and (C) anti-CD81 antibody
capture), (D) phosphatidylserine-positive (PSþ) small EVs (lactadherin capture), and small EV subtypes exposing specific antigens ((E) anti–
tissue factor (TF), (F) anti-CD41, (G) anti-CD146, and (H) anti-CD62E antibody capture) as semi-quantified by use of EV Array with an “exosome
cocktail” consisting of fluorescently labeled antibodies against CD9, CD63, and CD81 as detecting agents. Lines combine fasting levels (open
circles) with postprandial levels (closed circles) for each study participant. A.U., arbitrary units.
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Discussion
In this study, we aimed to evaluate the effect of a shift from
fasting to postprandial state on blood plasma levels of
particlesmeasuredwith FC and EVsmeasuredwith EVArray,
especially of TF-bearing subtypes. Using FC, we observed
significantly increased postprandial plasma levels of total
particles, TF-bearing particles (PS as well as PSþ particles),
total PSþ particles, and subtypes exposing antigens indicat-
ing platelet and endothelial origin in the postprandial as
compared with the fasting state. In vitro addition of lipo-
proteins to PFP also induced increased levels of all types of
particles measured by FC in this study. No changes in total
levels of EVs measured with EV Array, PPL-CT, or circulating
TF Ag were observed postprandially and in no samples TF
activity was above the limit of detection. Therefore, the
seeming postprandial increases in MV concentrations (rely-
ing on the assumption that PSþ events represent MVs)
measured with FC may, at least partially, be artifacts.
The postprandial increase in total particle concentration
was expected and the magnitude of the increase agreed well
with observations on the same study population counting
particles by use of TRPS showing a median postprandial
increase in particle concentrations by close to 1,400%.12
Intestinal lipid absorption is followed by release of chylomi-
crons from enterocytes.30 We expect these TG-rich lipopro-
teins, which have diameters between 75 and 1,200 nm,30 to
represent the main part of the increased number of particles
measured after food intake. The positive correlation between
the concentration of TG and total number of particles in
the postprandial state supports this. The concentration of
VLDLs, another type of TG-rich lipoprotein particles, is
also markedly increased postprandially31,32 but we would
not expect single VLDL particles to be detected by FC as
their diameter is appreciably below 100 nm except from a
smaller fraction, named large VLDLs, with diameters up to
200 nm.14 Interestingly, the amount of PSþ particles also
increased considerably postprandially, but it is questionable
towhich degree the significant increases in PSþ particles and
the measured subtypes really reflect changes in the MV
population.
The nomenclature in the EV field is not consistent.8,13,33 A
distinction between MVs and exosomes, relying on their
exposure of PS and specific tetraspanins, respectively, has
been suggested but it is not possible in practice to differ-
entiate between these two types of EVs.18 Exosomes are
actually not necessarily PS-free.11 Although Lacroix et al
advocated that identifying PS on particles using lactadherin
seems preferable to distinguish true MV events from other
particles in the same size range,34 it has also been reported
that a substantial part of circulating MVs do not expose
measurable amounts of PS.18,24,35 Moreover, Shi et al
Table 2 Biological variation in procoagulant phospholipid–
dependent clotting time (PPL-CT) and tissue factor antigen
(TF Ag) levels in platelet-free plasma (PFP)
Study Mean  SD
PL-CT,a (s)
Fasting state 71.3  13.7
Postprandial state 72.6  9.2
TF AgELISA,
b (pg/mL)
Fasting state 217  60
Postprandial state 211  53
TF AgEV Array,
a (AU)
Fasting state 1.54  1.16
Postprandial state 1.78  1.35
Abbreviations: AU, arbitrary units.
an ¼ 20.
bFor one subject, no ELISA results were obtained; hence, n ¼ 19 for this
method.
Fig. 5 Fasting and postprandial results on (A) procoagulant phospholipid–dependent clotting time (PPL-CT), (B) tissue factor antigen (TF Ag)
concentration as measured by ELISA, (C) TF Ag content as semi-quantified by EV Array using anti-TF antibodies as both capturing and detecting
agent, (D) total cholesterol concentration, and (E) triglyceride (TG) concentration. Lines combine fasting levels (open circles) with postprandial
levels (closed circles) for each study participant. A.U., arbitrary units.
TH Open Vol. 2 No. 2/2018
Lipoproteins and Extracellular Vesicle Analysis Mørk et al.e154
mentioned the possibility of lactadherin binding to lipopro-
teins that may themselves display PS.20 With regard to
exosomes, while tetraspanins considered to be exosome
markers, i.e., CD9, CD63, and CD81,36 are particularly abun-
dant in the membranes of exosomes, they are also found in
MVs.22 Hence, we have designated particles detected by EV
Array “small EVs” and particles detected with FC “PSþ
particles” or “PS particles.”
Thecombinationof lactadherin for labelingparticles expos-
ing PS and an antibody for labeling cell type markers should
theoretically help prevent lipoproteins from being mistaken
forMVs.However, thefact that all thesubtypesofPSþparticles
that we measured in this study were more abundant in the
postprandial statemay indicate that FC counts of PSþ particles
including any subgroupexisting inPFPare ingeneral increased
as a result of interference from lipoproteins. Indeed, whenwe
spiked plasma samples with VLDL or LDL, the results clearly
indicated that the in vitro admixture of either type of lipo-
protein prompted elevations of all examined subtypes of
particles, although the magnitude of the rise varied substan-
tially among the different subtypes, with the increase in
CD41þ particles being least pronounced. Sódar et al recently
demonstrated that LDLs do in fact adhere to MVs as well as to
exosomes when mixed with them in vitro.13 It could be
speculated that LDLs adhering to vesicles smaller than those
normally detectable by FC cause formation of fluorescently
labeled particles large enough for light scatter–based detec-
tion. However, even without the occurrence of adhesion,
lipoproteins and EVs simultaneously passing the optical sys-
tem of the flow cytometer may conceivably be mistaken for a
fluorescent particle within the size range detectable by FC,
thus causing a variant of the phenomenon termed swarm
detection.37 Such mechanisms could explain the apparent
increase in the antibody-labeled subtypes of PSþ particles
postprandially. The TFþ PS particles observed in our study
may represent TFþ MVs that did not expose measurable
amountsofPSorpossiblyTFþexosomesattachedtoor “swarm
detected” along with lipoproteins.
Our spiking study has some limitations. We did not add
chylomicrons, which appear in high amounts in the true
postprandial state. The sizes of LDLs and VLDLs in the added
suspensions probably differ from their in vivo counterparts
since previous studies have shown that the isolates contain
particles with larger diameters than normally described for
LDLs and VLDLs, probably due to aggregates of the lipopro-
tein particles.38 FC of the samples spiked with VLDL or LDL
was performed later and on other plasmas and other batches
of antibodies, and consequently the numbers of particles
were somewhat different from the first experiments. Never-
theless, the relative increases (experiments performed at the
same time with the same type of antibodies) were clearly
significant (►Table 1), and the results indicate that lipopro-
teins do interfere with the FC measurements. Also, we
considered the possibility that the commercially purchased
LDL and VLDL isolates may themselves contain some PSþ EV
residuals, since co-purification of EVs and lipoproteins is a
knownphenomenon.13However, addition of LDLs andVLDLs
in a solution containing PBS instead of PFP did not produce
antibody-labeled events, indicating that this should not be a
major source of error.
Although an artifactual effect on FC results of lipoproteins
appearing postprandially is likely and although plasma con-
tent of smaller EVs measurable by EV Array did not change
upon food intake, it is possible that part of the postprandial
increase in antibody-labeled PSþparticlesmayactually bedue
to cellular MV release. Notably, among the PSþ particles, the
CD62Eþ fraction increased markedly more than the others,
indicating a distinct effect on this subtype, which may reflect
an increase in MVs from activated endothelial cells. Mechan-
istically, a rise in the number of CD62Eþ PSþMVs is plausible
as increased plasma levels of TG have been shown to cause
endothelial activation39,40 and MVs can be released in
response to cell activation.41 Ferreira et al reported that
postprandial hypertriglyceridemia induced elevated levels of
endothelium-derived MVs both in the early (1 hour) post-
prandial phase and 3 hours after food intake. That study also
Fig. 6 (A) Correlation between tissue factor antigen (TF Ag) levels as measured by ELISA and EV Array in postprandial samples (Pearson’s
r ¼ 0.73; p < 0.001). (B) Correlation between triglyceride (TG) concentration and total particle concentration measured by flow cytometry in
postprandial samples (Spearman’s rs ¼ 0.79; p < 0.0001). A.U., arbitrary units.
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relied on FC forMVdetection,42 thus being subject to the same
type of possible interference from lipoproteins as the present
study. Platelets can also be activated in the postprandial
state.43,44 Interestingly, Michelsen et al described elevated
postprandial concentrations of platelet-derived MVs after a
fat-rich meal using a non-FC-based immunometric method
reportedly displaying a linear relation to FC results onplatelet-
derived MVs.45 Our FC results on subtypes of CD41 þ PSþ
particles are consistent with these findings. Further elucida-
tion of the potential interactions between MVs and lipopro-
teins and the relative contribution of either to the increase in
cell type marker– and PS-bearing events measured by FCmay
be possible by addition of lipoprotein markers (e.g., anti-
apolipoprotein B) or by detergent-based lysis of EVs as applied
by Sódar et al.13
The existence of circulating TF-bearing EVs in blood from
healthy subjects has been described,6,46 although it has also
been stated that cells do not shed TF-bearing EVs under
nonpathological conditions.47 Since our various measure-
ments of TF did not correlate very well, we clearly measured
different populations of TF. However, consistency between
fasting and postprandial EVArray results indicated that small
TFþ EVs are not significantly influenced by food ingestion,
whereas the reason for the postprandial increase of TFþ
particles (PSþ and PS) remains debatable. It would have
been advantageous to measure TF activity but the results
demonstrating levels below the limit of detection in all
plasma samples are in accordancewith thefindings byothers
on healthy individuals.48,49 Measurement of TF Ag may not
solelymeasure active TF but the unaltered postprandial level
indicates no major change of TF concentration postpran-
dially. This is in accordance with the suggestion that the
increase inTFþ particlesmeasuredwith FC primarily reflects
a higher number of small EVs adhering to or “swarming”
alongside lipoproteins in formations that are large enough to
be detected by FC rather than de novo release of TFþ MVs.
The finding that TF Ag levels are unaltered by food intake
contrasts observations described byMotton et al.48However,
postprandial blood samples in that studywere drawn3.5 and
6 hours following a standardized 40% fat meal that induced
an increase inmeanTG concentration byover 100% (3.5 hours
postprandial), whereas themean postprandial increase inTG
concentration in our study confined itself to 22%. The post-
prandial samples in our study were drawn at a feasible time
for blood sampling of patients in the morning after a normal
breakfast. Sódar et al showed that the concentration of
particles was almost maximal after 90 minutes.13
Regarding PPL levels, our data demonstrated that
although the amount of PSþ particles detectable by FC
increased significantly in the postprandial state, this was
not accompanied by a change in the coagulation state that
can be monitored by PPL-CT. Tushuizen et al found that the
total amount of PS in MV fractions was unaffected by food
intake in healthy subjects, although PSþ MV concentration
increased.16 This corresponds well with the apprehension
that a considerable part of the apparent postprandial
increase in the concentration of PSþ particles may be an
artifact resulting from increased lipoprotein interference.
Conclusion
Food ingestion resulted in elevated plasma levels of PSþ
particles, including subgroups exposing TF and other antigen
markers measured by FC. While the observed postprandial
increase may to some extent reflect elevated MV levels, the
finding that in vitro addition of lipoproteins to fasting plasma
had a similar effect suggests that itmayat least partly bedue to
postprandially appearing lipoproteins. Thus, PSþ events that
are also positive for TF or cell-specific antigen markers should
not uncritically be interpreted as MVs, when performing FC-
based investigations on MVs in blood.
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